Exploring the gut microbiome and head and neck cancer interplay

Area of Science:

• Microbiology
• Immunology
• Oncology

Background:

• The gut microbiome is vital for human health.
• Microbial imbalances (dysbiosis) are linked to immune dysfunction and inflammation.
• This dysbiosis can promote cancer development.

Purpose of the Study:

• To review the impact of gut microbiome dysbiosis on immune function, inflammation, and cancer.
• To explore the role of gut metabolites in these processes.
• To highlight potential microbiome-targeted therapies for cancer prevention and treatment.

Main Methods:

• Literature review of studies on gut microbiome, dysbiosis, and cancer.
• Analysis of the role of microbial metabolites (e.g., SCFAs, bile acids).
• Discussion of therapeutic interventions like probiotics, prebiotics, and diet.

Main Results:

• Gut dysbiosis contributes to immune dysfunction and a pro-inflammatory state.
• This state is conducive to tumorigenesis, particularly in Head and Neck Cancer (HNC).
• Microbiome metabolites significantly modulate these processes.

Conclusions:

• Targeting the gut microbiome offers potential for HNC prevention and treatment.
• Restoring microbial balance through probiotics, prebiotics, or diet may mitigate cancer risk.
• Further research is needed to understand specific microbial roles and lifestyle impacts for personalized strategies.